연구성과로 돌아가기

2023 연구성과별 연구자 정보 (1485 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Lee, Jeong Yeop Lee, JY 7 Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Lee, Jeong Yeop Lee, JY 7 Chonnam Natl Univ, Med Sch, Dept Radiol, Hwasun, Jeonnam, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Lee, Jae Cheol Lee, JC 8 Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Choi, Chang Min Choi, CM 9 Univ Ulsan, Asan Med Ctr, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Ji, Wonjun Ji, WJ 10 Univ Ulsan, Asan Med Ctr, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Song, Si Yeol Song, SY 11 Univ Ulsan, Asan Med Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Choi, Juwhan Choi, J 12 Korea Univ, Guro Hosp, Dept Internal Med, Coll Med, Seoul, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Lee, Sung Yong Lee, SY 13 Korea Univ, Guro Hosp, Dept Internal Med, Coll Med, Seoul, South Korea A-3892-2015 Lee, Sang-Jun 0000-0002-8693-5792 LEE, SUNG YONG droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Kim, Hakyoung Kim, H 14 Korea Univ, Coll Med, Dept Radiat Oncol, Guro Hosp, Seoul, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Lee, Shin Yup Lee, SY 15 Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Park, Jongmoo Park, J 16 Kyungpook Natl Univ, Sch Med, Dept Radiat Oncol, Daegu, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Yoon, Seong Hoon Yoon, SH 17 Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Sch Med, Yangsan, Gyeongnam, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Joo, Ji Hyeon Joo, JH 18 Pusan Natl Univ, Yangsan Hosp, Dept Radiat Oncol, Sch Med, Yangsan, Gyeongnam, South Korea droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Oh, In-Jae Oh, IJ 19 교신저자 Chonnam Natl Univ, Med Sch, Dept Internal Med, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea AAG-5919-2020 Oh, In-Jae 0000-0003-4837-1321 Oh, In-Jae droij@jnu.ac.kr;
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR Oh, In-Jae Oh, IJ 19 교신저자 Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea AAG-5919-2020 Oh, In-Jae 0000-0003-4837-1321 Oh, In-Jae droij@jnu.ac.kr;
페이지 이동: